Status:
RECRUITING
ACT With CF Self-Help Toolkit
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Boomer Esiason Foundation
Conditions:
Cystic Fibrosis (CF)
Depressive and Anxiety Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depressi...
Detailed Description
State the primary objective(s) of the study: The objective of the study is to assess the effectiveness of "ACT with CF Self Help Toolkit" in improving cognitive fusion, depression, anxiety, psycholog...
Eligibility Criteria
Inclusion Criteria:
- 18 years or older
- Existing diagnosis of cystic fibrosis
- PHQ-9 score >4 or GAD-7 score >4
Exclusion Criteria:
- History of suicide attempts or acute suicidal ideation on clinical assessment
- Presence of psychotic disorder or symptoms
- Presence of psychiatric disorders that interfere with participation in the study, judged by the study or treating clinician
- Presence of other medical conditions that interfere with participation in the study, judged by the study or treating clinician
Key Trial Info
Start Date :
January 20 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07436351
Start Date
January 20 2026
End Date
April 1 2027
Last Update
March 3 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107